Source:http://linkedlifedata.com/resource/pubmed/id/12391242
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
2002-10-22
|
| pubmed:abstractText |
Lymphotoxin-alpha(-/-) (LTalpha(-/-)) mice are thought to be unable to generate effective T and B cell responses. This is attributed to the lack of lymph nodes and the disrupted splenic architecture of these mice. However, despite these defects we found that LTalpha(-/-) mice could survive infection with a virulent influenza A virus. LTalpha(-/-) mice and normal wild-type mice infected with influenza A generated similar numbers of influenza-specific CD8 T cells that were able to produce IFN-gamma and kill target cells presenting influenza peptides. Furthermore influenza-infected LTalpha(-/-) mice produced high titers of influenza-specific IgM, IgG, and IgA. However, both CD8 and B cell immune responses were delayed in LTalpha(-/-) mice by 2-3 days. The delayed cellular and humoral immune response was sufficient to mediate viral clearance in LTalpha(-/-) mice that were infected with relatively low doses of influenza virus. However, when LTalpha(-/-) mice were infected with larger doses of influenza, they succumbed to infection before the immune response was initiated. These results demonstrate that neither LTalpha nor constitutively organized lymphoid tissues, such as lymph nodes and spleen, are absolutely required for the generation of effective immunity against the respiratory virus influenza A. However, the presence of LTalpha and/or lymph nodes does accelerate the initiation of immune responses, which leads to protection from larger doses of virus.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0022-1767
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
169
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
5236-43
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:12391242-Animals,
pubmed-meshheading:12391242-Antibody Specificity,
pubmed-meshheading:12391242-B-Lymphocytes,
pubmed-meshheading:12391242-CD8-Positive T-Lymphocytes,
pubmed-meshheading:12391242-Cells, Cultured,
pubmed-meshheading:12391242-Cytotoxicity, Immunologic,
pubmed-meshheading:12391242-Epitopes, T-Lymphocyte,
pubmed-meshheading:12391242-Genetic Predisposition to Disease,
pubmed-meshheading:12391242-Germinal Center,
pubmed-meshheading:12391242-Immunoglobulin Isotypes,
pubmed-meshheading:12391242-Influenza A virus,
pubmed-meshheading:12391242-Interferon-gamma,
pubmed-meshheading:12391242-Lung,
pubmed-meshheading:12391242-Lymphotoxin-alpha,
pubmed-meshheading:12391242-Mice,
pubmed-meshheading:12391242-Mice, Inbred C57BL,
pubmed-meshheading:12391242-Mice, Knockout,
pubmed-meshheading:12391242-Orthomyxoviridae Infections,
pubmed-meshheading:12391242-Spleen,
pubmed-meshheading:12391242-T-Lymphocyte Subsets,
pubmed-meshheading:12391242-Time Factors,
pubmed-meshheading:12391242-Viral Load
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza.
|
| pubmed:affiliation |
Trudeau Institute, Saranac Lake, NY 12983, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|